Division of Head and Neck Surgery, Department of Surgery, United Christian Hospital, Hong Kong.
Division of Head and Neck Surgery, Department of Surgery, United Christian Hospital, Hong Kong.
Am J Otolaryngol. 2019 May-Jun;40(3):431-434. doi: 10.1016/j.amjoto.2019.04.001. Epub 2019 Apr 2.
There is much debate in the literature over the extent of surgery for patients with intermediate risk papillary thyroid cancer. We herein report our results in a local tertiary hospital.
We identify from our database patients with papillary thyroid cancer who underwent surgery in our hospital and were stratified to be of intermediate risk from the GAMES stratification system. Patients' demographic data, surgical and pathological details were recorded. Primary end points were disease specific survival (DSS) and recurrence free survival (RFS).
From January 1993 to December 2016, 231 patients with papillary thyroid cancer underwent surgery of which 137 (59%) were of intermediate risk. 45 (33%) patients had hemithyroidectomy and 92 (67%) patients had total thyroidectomy. In the total thyroidectomy group, patients had a higher tumor (T) (p value = 0.009) and nodal (N) staging (p value = 0.001). They were also predicted to have a higher risk of recurrence according to the American Thyroid Association (ATA) classification (p value = 0.005). The 5 year DSS in both groups were 100%. The 5 year RFS in the total thyroidectomy and hemithyroidectomy groups were 92% and 100% respectively and were significantly different by the log rank test (p value = 0.02). The median follow up time was 54 months (range 4-276 months).
The 5 year survival in intermediate risk papillary thyroid cancer is favorable. Hemithyroidectomy is an acceptable choice of operation in intermediate risk patients with a better risk profile.
文献中对于中危型甲状腺乳头状癌患者的手术范围存在很大争议。在此,我们报告了我们在一家本地三级医院的研究结果。
我们从数据库中确定了在我院接受手术治疗且根据 GAMES 分层系统被归类为中危型的甲状腺乳头状癌患者。记录患者的人口统计学数据、手术和病理细节。主要终点是疾病特异性生存率(DSS)和无复发生存率(RFS)。
1993 年 1 月至 2016 年 12 月,231 例甲状腺乳头状癌患者接受了手术治疗,其中 137 例(59%)为中危型。45 例(33%)患者行甲状腺半切除术,92 例(67%)患者行甲状腺全切除术。在甲状腺全切除术组中,患者的肿瘤(T)分期(p 值=0.009)和淋巴结(N)分期更高(p 值=0.001)。根据美国甲状腺协会(ATA)分类,他们也被预测为复发风险更高(p 值=0.005)。两组的 5 年 DSS 均为 100%。甲状腺全切除术和甲状腺半切除术组的 5 年 RFS 分别为 92%和 100%,对数秩检验差异有统计学意义(p 值=0.02)。中位随访时间为 54 个月(范围 4-276 个月)。
中危型甲状腺乳头状癌的 5 年生存率良好。对于风险状况较好的中危型患者,甲状腺半切除术是一种可接受的手术选择。